All premium reports for Pathology Industry Analysis and Statistics (since 2008 - p5)

 

121-150 of 216 Premium Reports from 19 Publishers

Infections AIDS HIV

Infections AIDS HIV

  • $ 1 495
  • March 2009

Life Science Analytics', Infections AIDS HIV contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of aids drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the report:Each Life Sci ...

Industries : Pathology

Infections Diphtheria

Infections Diphtheria

  • $ 1 495
  • March 2009

Life Science Analytics', Infections Diphtheria contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of diphtheria drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the report:Each ...

Industries : Pathology

Infections Ear Infections

Infections Ear Infections

  • $ 1 495
  • March 2009

Life Science Analytics', Infections Ear Infections contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of ear infections drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the repo ...

Industries : Pathology

Infections Fever

Infections Fever

  • $ 1 495
  • March 2009

Life Science Analytics', Infections Fever contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of fever drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the report:Each Life Scien ...

Industries : Pathology

Infections Fungal Infections or Candidiasis

Infections Fungal Infections or Candidiasis

  • $ 1 495
  • March 2009

Life Science Analytics', Infections Fungal Infections or Candidiasis contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of fungal infections or candidiasis drugs by company and by stage as well as a summary of the latest news and develop ...

Industries : Pathology

Infections Helminthic Infestations

Infections Helminthic Infestations

  • $ 1 495
  • March 2009

Life Science Analytics', Infections Helminthic Infestations contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of helminthic infestations drugs by company and by stage as well as a summary of the latest news and developments in this area ...

Industries : Pathology

Infections Hepatitis B

Infections Hepatitis B

  • $ 1 495
  • March 2009

Life Science Analytics', Infections Hepatitis B contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of hepatitis b drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the report:Eac ...

Industries : Pathology

Infections Hepatitis C

Infections Hepatitis C

  • $ 1 495
  • March 2009

Life Science Analytics', Infections Hepatitis C contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of hepatitis c drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the report:Eac ...

Industries : Pathology

Infections Hepatitis

Infections Hepatitis

  • $ 1 495
  • March 2009

Life Science Analytics', Infections Hepatitis contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of hepatitis drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the report:Each Li ...

Industries : Pathology

Infections Herpes Simplex Virus Infection

Infections Herpes Simplex Virus Infection

  • $ 1 495
  • March 2009

Life Science Analytics', Infections Herpes Simplex Virus Infection contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of herpes simplex virus infection drugs by company and by stage as well as a summary of the latest news and development ...

Industries : Pathology

Infections Influenza

Infections Influenza

  • $ 1 495
  • March 2009

Life Science Analytics', Infections Influenza contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of influenza drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the report:Each Li ...

Industries : Pathology

Infections Malaria

Infections Malaria

  • $ 1 495
  • March 2009

Life Science Analytics', Infections Malaria contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of malaria drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the report:Each Life S ...

Industries : Pathology

Infections Onychomycosis

Infections Onychomycosis

  • $ 1 495
  • March 2009

Life Science Analytics', Infections Onychomycosis contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of onychomycosis drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the report ...

Industries : Pathology

Infections Pneumonia

Infections Pneumonia

  • $ 1 495
  • March 2009

Life Science Analytics', Infections Pneumonia contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of pneumonia drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the report:Each Li ...

Industries : Pathology

Infections Sepsis

Infections Sepsis

  • $ 1 495
  • March 2009

Life Science Analytics', Infections Sepsis contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of sepsis drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the report:Each Life Sci ...

Industries : Pathology

Infections Skin and Soft Tissue Infections

Infections Skin and Soft Tissue Infections

  • $ 1 495
  • March 2009

Life Science Analytics', Infections Skin and Soft Tissue Infections contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of skin and soft tissue infections drugs by company and by stage as well as a summary of the latest news and developme ...

Industries : Pathology

Infections Staphylococcal Infections

Infections Staphylococcal Infections

  • $ 1 495
  • March 2009

Life Science Analytics', Infections Staphylococcal Infections contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of staphylococcal infections drugs by company and by stage as well as a summary of the latest news and developments in this ...

Industries : Pathology

Infections Tetanus

Infections Tetanus

  • $ 1 495
  • March 2009

Life Science Analytics', Infections Tetanus contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of tetanus drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the report:Each Life S ...

Industries : Pathology

Infections Throat Infection

Infections Throat Infection

  • $ 1 495
  • March 2009

Life Science Analytics', Infections Throat Infection contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of throat infection drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the ...

Industries : Pathology

Infections Tuberculosis

Infections Tuberculosis

  • $ 1 495
  • March 2009

Life Science Analytics', Infections Tuberculosis contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of tuberculosis drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the report:E ...

Industries : Pathology

Infections Urinary Tract Infections

Infections Urinary Tract Infections

  • $ 1 495
  • March 2009

Life Science Analytics', Infections Urinary Tract Infections contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of urinary tract infections drugs by company and by stage as well as a summary of the latest news and developments in this a ...

Industries : Pathology

Infections Viral Infections

Infections Viral Infections

  • $ 1 495
  • March 2009

Life Science Analytics', Infections Viral Infections contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of viral infections drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the ...

Industries : Pathology

Respiratory and Pulmonary System Asthma

Respiratory and Pulmonary System Asthma

  • $ 1 495
  • March 2009

Life Science Analytics', Respiratory and Pulmonary System Asthma contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of asthma drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of th ...

Industries : Pathology

Respiratory and Pulmonary System Bronchitis

Respiratory and Pulmonary System Bronchitis

  • $ 1 495
  • March 2009

Life Science Analytics', Respiratory and Pulmonary System Bronchitis contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of bronchitis drugs by company and by stage as well as a summary of the latest news and developments in this area.Sco ...

Industries : Pathology

Respiratory and Pulmonary System Bronchospasm

Respiratory and Pulmonary System Bronchospasm

  • $ 1 495
  • March 2009

Life Science Analytics', Respiratory and Pulmonary System Bronchospasm contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of bronchospasm drugs by company and by stage as well as a summary of the latest news and developments in this area ...

Industries : Pathology

Respiratory and Pulmonary System Chronic Obstructive Pulmonary Disease

Respiratory and Pulmonary System Chronic Obstructive Pulmonary Disease

  • $ 1 495
  • March 2009

Life Science Analytics', Respiratory and Pulmonary System Chronic Obstructive Pulmonary Disease contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of chronic obstructive pulmonary disease drugs by company and by stage as well as a summa ...

Industries : Pathology

Respiratory and Pulmonary System Cough

Respiratory and Pulmonary System Cough

  • $ 1 495
  • March 2009

Life Science Analytics', Respiratory and Pulmonary System Cough contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of cough drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the ...

Industries : Pathology

Respiratory and Pulmonary System Cystic Fibrosis

Respiratory and Pulmonary System Cystic Fibrosis

  • $ 1 495
  • March 2009

Life Science Analytics', Respiratory and Pulmonary System Cystic Fibrosis contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of cystic fibrosis drugs by company and by stage as well as a summary of the latest news and developments in thi ...

Industries : Pathology

Respiratory and Pulmonary System Nasal congestion

Respiratory and Pulmonary System Nasal congestion

  • $ 1 495
  • March 2009

Life Science Analytics', Respiratory and Pulmonary System Nasal congestion contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of nasal congestion drugs by company and by stage as well as a summary of the latest news and developments in t ...

Industries : Pathology

Respiratory and Pulmonary System Pulmonary Fibrosis

Respiratory and Pulmonary System Pulmonary Fibrosis

  • $ 1 495
  • March 2009

Life Science Analytics', Respiratory and Pulmonary System Pulmonary Fibrosis contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of pulmonary fibrosis drugs by company and by stage as well as a summary of the latest news and developments ...

Industries : Pathology

reportlinker.com © Copyright 2009. All rights reserved

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.